Tramadol

Cipher receives tentative FDA approval for extended-release tramadol capsules

Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Feb. 17 /PRNewswire-FirstCall/ - Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has received tentative approval from the U.S. Food and Drug Administration (FDA) for CIP-TRAMADOL ER, the Company's extended-release formulation ...

Labopharm's Once-Daily Tramadol Product Launched in South Korea, Australia, Romania and Austria

- Product Now Being Sold in 14 Countries Worldwide - LAVAL, QC, July 31 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that its once-daily formulation of tramadol has been launched in the following countries: South Korea - Labopharm's marketing partner for...

FDA accepts Labopharm's response for once-daily tramadol as complete Class 2 response

- FDA Assigns PDUFA Date of January 2, 2009 - LAVAL, QC, July 17 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that the response that it submitted to the U.S. Food and Drug Administration (FDA) on July 2, 2008, including the additional analysis of existing ...

Labopharm Reaquires UK Sales And Marketing Rights to Its Once-Daily Tramadol Product

- Company to Engage Contract Sales Organization And Seek New Marketing Partner to Promote Product in UK - LAVAL, QC, July 7 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it has reacquired the sales and marketing rights to its once-dail...

Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product

- Company Expects to Submit Complete Response by End of Week - LAVAL, QC, June 30 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that the Company has received a response from the U.S. Food and Drug Administration (FDA) regarding its most recent appeal of ...

Labopharm Appeals FDA's Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy

- Company Believes That Continuing to Follow Dispute Resolution Process is the Most Expeditious Path to Final Approval - LAVAL, QC, April 1 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it has appealed the U.S. Food and Drug Administration's (...

Labopharm's Once-Daily Tramadol Approved in South Korea and Australia

- Company Enters Into Marketing Partnership for Once-Daily Tramadol for Turkey - LAVAL, QC, Feb. 13 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that its once-daily tramadol product has received regulatory approval from the Kor...

Canadian Marketing and Sales Effort for Labopharm's Once-Daily Tramadol Product to Expand Significantly

- Labopharm's Canadian Marketing Partner, Paladin, Enters Into Co- Promotion Agreement with Nycomed Canada - LAVAL, QC, Feb. 1 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS, NASDAQ: DDSS) today announced that its Canadian licensing and distribution partner for its once-dai...

Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova

LAVAL, QC, Jan. 24 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS, NASDAQ: DDSS) today announced that it has entered into a licensing and distribution agreement with iNova Pharmaceuticals (Australia) Pty Limited for its once-daily tramadol product for Australia. "Building on the launch of...

Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy

- Article Discussing Analgesic Efficacy of Labopharm's Once-Daily Tramadol Published in Journal of Pain and Symptom Management - - Company Secures Marketing Partner for Once-Daily Tramadol in Israel - LAVAL, QC, Sept. 14 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS)...

Tramadol in Medical Technology

Advances in Science and Treatment of Pain Presented at 25th Annual American Academy of Pain Medicine Meeting January 28 - 31, 2009

...from 9-10 AM Calcium Channel Blockers Compared for Neuropathic Pain, Poster 181 Addictive Qualities of Cannabinoid Medication, Poster 193 tramadol Outcomes, Poster 197 Safety, Tolerability and Effectiveness of Duloxetine for Fibromyalgia, Poster 204 Effects of Oral Oxycodone in Recre...

Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine

...s and Dose Proportionality of Company's Once-Daily tramadol to be Published in Biopharmaceutics Journal - LAV...he dose titration of its once-daily formulation of tramadol at the 3rd International Forum on Pain Medicine to...chedules for Labopharm's once-daily formulation of tramadol in three Phase III clinical trials: a six-day titr...

Tramadol in Biological News

Codeine use and accident risk

...wegian Institute of Public Health. Codeine and tramadol are painkillers in the opiate group, used for mild...ent Register was used to study whether codeine- or tramadol users have an increased risk of being involved in ...the dispensing of a prescription for a codeine- or tramadol preparation. The study showed that the risk of...

Tramadol in Biological Technology

Circ Pharma Limited Enters Into Development Agreement for Chrono Tramadol With Elan Corporation Plc

DUBLIN, May 4 /PRNewswire/ -- Circ Pharma Limited ("Circ Pharma") and Elan Corporation plc ("Elan") today announced that they have entered into a Development Agreement to develop a chronotherapeutic formulation of Tramadol for the treatment of moderate to moderately severe pain. The pro...

Tramadol in Biological Definition

Drug

...etic opioids Heroin Oxycodone (sold under the brand name Oxycontin, and contained in Percocet ) Vicodin Demerol Darvocet tramadol Fentanyl Recreational drugs usually used to alter mood or body function for recreation Alcohol Nicotine Caffeine ...